| Adenosine deaminase |
Km |
= |
553600.0 |
nM |
Michaelis-Menten constant for Calf intestinal mucosa adenosine deaminase was determined |
CHEMBL1127724 |
| Adenosine deaminase |
Vmax |
= |
0.000104 |
uM min-1 unit-1 |
Vmax for Calf intestinal mucosa adenosine deaminase was determined |
CHEMBL1127724 |
| Vero |
ID50 |
= |
3.3 |
uM |
Antiviral activity was determined in plaque reduction assay in vero cells against HSV-1 F strain |
CHEMBL1122960 |
| Mus musculus |
Survival |
= |
7.0 |
|
Effect of oral treatment on HSV-2 encephalitis infection in mice and survivors/total was reported at a dose 40 mg/kg; 7/20 |
CHEMBL1122960 |
| Mus musculus |
Survival |
= |
5.0 |
|
Effect of oral treatment on HSV-2 encephalitis infection in mice and survivors/total was reported at a dose 20 mg/kg; 5/20 |
CHEMBL1122960 |
| Mus musculus |
Survival |
= |
4.0 |
|
Effect of oral treatment on HSV-2 encephalitis infection in mice and survivors/total was reported at a dose 10 mg/kg; 4/20 |
CHEMBL1122960 |
| Mus musculus |
Survival time |
= |
11.5 |
day |
Effect of oral treatment on HSV-2 encephalitis infection in mice and mean survival time was reported at a dose 40 mg/kg |
CHEMBL1122960 |
| Mus musculus |
Survival time |
= |
10.9 |
day |
Effect of oral treatment on HSV-2 encephalitis infection in mice and mean survival time was reported at a dose 20 mg/kg |
CHEMBL1122960 |
| Mus musculus |
Survival time |
= |
10.8 |
day |
Effect of oral treatment on HSV-2 encephalitis infection in mice and mean survival time was reported at a dose 10 mg/kg |
CHEMBL1122960 |
| Adenosine deaminase |
Km |
= |
553600.0 |
nM |
Substrate activity at calf Intestinal mucosa adenosine deaminase assessed as km by Lineweaver-Burk plot analysis |
CHEMBL4613261 |
| Adenosine deaminase |
Vmax |
= |
1.04 |
10'-3umol/min/U |
Substrate activity at calf Intestinal mucosa adenosine deaminase assessed as Vmax by Lineweaver-Burk plot analysis |
CHEMBL4613261 |